Current Opinion in Allergy and Clinical Immunology

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	51
The pathogenetic role of Th17 immune response in atopic dermatitis	34
The use of environmental exposure chambers in studies related to ocular surface effects	30
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	29
Liver disease in primary antibody deficiencies	26
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	25
Economic burden of drug-induced anaphylaxis: what can we do better?	22
Consequences of severe asthma exacerbations	21
Dietary strategies for the prevention of asthma in children	21
Anaphylaxis due to antiallergic and antiasthmatic biologics	18
Pulmonary function testing for the diagnosis of asthma in preschool children	17
Cow's milk allergy	17
E-cigarettes and asthma in adolescents	16
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	16
Real-world evidence of allergen immunotherapy	15
Is immunotherapy safe for treatment of severe asthma	15
New approaches in childhood asthma treatment	14
Mast cell conditions and drug allergy: when to suspect and how to manage	14
Role of pharmacogenomics in T-cell hypersensitivity drug reactions	14
Innate and adaptive immunity in allergic airway disease	13
Editorial: Food allergy: from defense to attack	12
Atopic manifestations of inborn errors of immunity	12
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	12
Update on occupational allergy, including asthma, to soluble platinum salts	12
Ocular involvement in allergic drug reactions	11

Editorial introductions	11
Editorial introductions	11
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	11
The effects of the COVID-19 pandemic on the treatment of allergic eye diseases	11
Transition of care in inborn errors of immunity	10
Perioperative anaphylaxis: when the allergological work-up goes negative	10
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	10
Vernal keratoconjunctivitis and keratoconus	10
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	10
Biologics as treatment options for anaphylaxis	10
Editorial introductions	9
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	9
Updates in diagnosis and management of paediatric mastocytosis	9
Autologous serum eye drops for ocular surface disorders	9
Editorial introductions	9
An immunologist's perspective on anti-COVID-19 vaccines	9
Drug allergy desensitization is not a unique recipe	9
Biological therapies, asthma and coronavirus disease 2019	9
Nanoparticles in allergen immunotherapy	9
Editorial introductions	9
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	8
A review of food allergy-related costs with consideration to clinical and demographic factors	8
Health disparities in allergic diseases	8
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	8
Editorial: Advances in drug hypersensitivity reactions	8
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	8
Updates in school-based asthma management	7
Management and treatment of perioperative hypersensitivity	7
Basophil activation test in food allergy: is it ready for real-time?	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Evaluating the glucagon-like peptide-1 receptor in managing asthma	7
Food-labeling issues for severe food-allergic consumers	7
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	6
Strengthening the case for intralymphatic immunotherapy	6
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	6
Occupational causes of chronic obstructive pulmonary disease: an update	6
Editorial introductions	6
Food allergy: new therapeutic options open deeper questions	6
Precision allergy molecular diagnosis applications in food allergy	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	6
Biomarkers in the diagnosis of mast cell activation	6
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	6
Current strategies for phenotyping and managing asthma in preschool children	6
Role of the ocular surface microbiome in allergic eye diseases	6
Clinical remission in severe asthma: lights and shadows on an ambitious goal	6
The complexity in DNA methylation analysis of allergic diseases	6
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	5
Giant cell arteritis and innovative treatments	5

Adverse effects of anti-cancer biologics on the ocular surface	5
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	5
Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease	5
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	5
Occupational respiratory allergy to reactive dyes	5
Immunobiologicals and ocular surface disease	5
Real-life studies in allergen immunotherapy	5
New causes of occupational allergic contact dermatitis	5
Interstitial lung diseases in inborn errors of immunity	5
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	5
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?	5
Precision medicine to personalize medicine in allergic airway disease	5
Precision medicine for cow's milk immunotherapy in clinical practice	5
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	5
The role of macrolides in chronic rhinosinusitis and nasal polyps	5
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	5
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	5
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	4
Anaphylaxis and digital medicine	4
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	4
Clinical outcomes of AIT in the elderly population	4
New evidence in food allergies treatment	4
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	4
Endotypes of occupational asthma	4
Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface	4
Editorial introductions	4
Omalizumab is the Columbus egg for food allergies	4
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	4
Role of biologics in severe food allergy	4
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	4
New insights in mite immunotherapy – sublingual tablets	4
Editorial introductions	4
The risk of anaphylaxis on holidays	4
MicroCrystalline Tyrosine-adsorbed immunotherapy	4
The development of the DEFASE project	4
An update on patient reported outcomes in type 2 inflammation airway disease	4
Anaphylaxis in elderly people	3
Perioperative anaphylaxis: updates on pathophysiology	3
Editorial introductions	3
Neurostimulation for dry eye disease	3
Moderate asthma: burden, mechanisms and therapeutic perspectives	3
Ocular surface disorders: office procedures for the allergist/clinical immunologist	3
Diagnosis, management and therapeutic options for eosinophilic esophagitis	3
Biologics and severe asthma in children	3
Management of food allergy based on oral food challenge	3
Recent advances in the diagnosis and management of tree nut and seed allergy	3
Editorial introductions	3
How E-cigarettes and vaping can affect asthma in children and adolescents	3
Editorial: Pharmacotherapy and evidence based medicine	3
Editorial introductions	3
Genetic landscape of atopic dermatitis	3
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	3
Editorial introductions	3
Corneal complications of rheumatoid arthritis	3
New insights into the mechanisms of aspirin-exacerbated respiratory disease	3
Editorial introductions	3
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	3
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	3
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications	3
The evolution of cyclosporine treatments for treatment of ocular surface diseases	3
Allergen immunotherapy, cancer, and immune disorders	2
Management of adverse reactions induced by chemotherapy drugs	2
Tryptase in drug-induced anaphylaxis: the need for acute and baseline values	2
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management	2
Long-term outcome of occupational asthma with different etiology	2
Regulatory T-cells in asthma	2
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	2
Biologicals in IgE-mediated food allergy	2
Predicting the course of asthma from childhood until early adulthood	2
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	2
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	2
Chronic urticaria: not only after COVID-19 vaccination	2
Drug allergy management in the elderly	2
Innate lymphoid cells in immunoglobulin E-mediated food allergy	2
Inborn errors of immunity underlying defective T-cell memory	2
Exposure to nanoparticles and occupational allergy	2
Perspectives in precautionary allergen labelling of prepackaged foods after the FAO/WHO consultation	2
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	2
Serum tryptase and drug hypersensitivity: why, how and what? A systematic review	2
Classifying cephalosporins: from generation to cross-reactivity	2

Anaphylaxis: glimpse into the future, attention to the present	2
Anaphylaxis viewed by experts: unmet needs	2
Biologics to treat anaphylaxis	2
Advances in gene therapy for inborn errors of immunity	2
Editorial introductions	2
Hereditary angioedema: current therapeutic management and future approaches	2
Clinically meaningful changes in efficacy outcomes in chronic rhinosinusitis with nasal polyposis	2
Artificial intelligence and machine learning for anaphylaxis algorithms	2
Upper and lower airway interactions in children	2
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	2
Clinical outcomes of efficacy in food allergen immunotherapy trials	2
Grading the severity of anaphylaxis	2
Psychosocial impact of ocular surface allergic inflammatory disorders	2
Integrative therapeutics for ocular surface disorders	2
Editorial introductions	2
Applying the new guidelines to asthma management in children	2
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	2
Severe asthma and personalized approach in the choice of biologic	2